On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples From Clinical Oncology Data

DOI10.2307/2290318zbMATH Open0775.62297OpenAlexW4249492944MaRDI QIDQ5288901FDOQ5288901

Authors: Jeffrey J. Gaynor, Eric J. Feuer, Claire C. Tan, Danny H. Wu, Claudia R. Little, David J. Straus, Bayard D. Clarkson, Murray F. Brennan 

Publication date: 7 September 1993

Full work available at URL: https://doi.org/10.2307/2290318

Mathematics Subject Classification ID

Nonparametric estimation (62G05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cited In (38)

• Semiparametric estimation for proportional hazards mixture cure model allowing non-curable competing risk
• Dependent competing risks: cause elimination and its impact on survival
• Inference for cumulative incidence on discrete failure times with competing risks
• Kernel regression for cause-specific hazard models with time-dependent coefficients
• Reliability studies of bivariate Birnbaum-Saunders distribution
• Bayesian approach for proportional hazards mixture cure model allowing non-curable competing risk
• Estimation with right-censored observations under a semi-Markov model
• A 3-parameter Gompertz distribution for survival data with competing risks, with an application to breast cancer data
• Title not available (Why is that?)
• Inference for the dependent competing risks model with masked causes of failure
• Estimation and modeling of the restricted mean time lost in the presence of competing risks
• Nonparametric quantile inference for cause-specific residual life function under length-biased sampling
• A competing risks analysis of the duration of federal target funds rates
• Assessing covariate effects using Jeffreys-type prior in the Cox model in the presence of a monotone partial likelihood
• Reliability studies of bivariate distributions with Pareto conditionals
• Reliability studies of bivariate distributions with exponential conditionals
• Reliability functions of bivariate distributions in modeling marked point processes
• A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data
• Fitting a Semi-Parametric Mixture Model for Competing Risks in Survival Data
• Proportional hazards model for competing risks data with missing cause of failure
• Book review of: J. Beyersmann et al., Competing risks and multistate models with R
• Bayesian inference of the fully specified subdistribution model for survival data with competing risks
• Kernel regression for cause-specific hazard models with nonparametric covariate functions
• Non-proportionality of hazards in the competing risks framework
• A Bayesian multi‐risks survival (MRS) model in the presence of double censorings
• A SURVIVAL ANALYSIS INCORPORATING AUXILIARY INFORMATION BY A BAYESIAN GENERALIZED METHOD OF MOMENTS: APPLICATION TO PURCHASE DURATION MODELING
• Semiparametric estimation based on parametric modeling of the cause-specific hazard ratios in competing risks
• Direct Parametric Inference for the Cumulative Incidence Function
• Nonparametric inference on cause-specific quantile residual life
• Assessing diagnostic accuracy improvement for survival or competing-risk censored outcomes
• Competing Risks Analysis of Correlated Failure Time Data
• Constrained parametric model for simultaneous inference of two cumulative incidence functions
• Accelerated failure time models for the analysis of competing risks
• Estimating subject-specific dependent competing risk profile with censored event time observa\-tions
• Statistical methods for dependent competing risks
• Statistical inference methods for cumulative incidence function curves at a fixed point in time
• Nonparametric inference under competing risks and selection-biased sampling
• Semiparametric estimation for accelerated failure time mixture cure model allowing non-curable competing risk

This page was built for publication: On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples From Clinical Oncology Data

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5288901)